Did you know that type 1 diabetes is the most common metabolic disease in children and adolescents?
We conduct studies in Belgium, Germany, the UK, Poland, and Sweden for the early detection of an increased genetic risk of type 1 diabetes and prevention of disease development.
WE RESEARCH. WE DEVELOP. WE FIGHT.
FOR A WORLD WITHOUT TYPE 1 DIABETES.
The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) was launched in 2015 and brings together several academic research institutions and hospitals in Europe. GPPAD aims to establish an international infrastructure for studies dedicated to preventing the development of type 1 diabetes.